Risperidone Long-acting injectable (LAI) suspension bulk supplier for pharma manufacturers

Risperidone Long-Acting Injectable (Lai) Suspension Suppliers & Bulk Manufacturers

Available Forms: Long-acting injectable (LAI) suspension

Available Strengths: 25 mg, 37.5 mg, 50 mg per dose

Reference Brands: Risperdal®(US & EU); EU: Risperidon-ratiopharm®, Rispolept®, Rispen®

Risperidone LAI is an atypical antipsychotic that works by antagonizing dopamine D2 and serotonin 5-HT2A receptors, balancing neurotransmission in the brain. It is indicated for the treatment of schizophrenia and bipolar I disorder in adults, providing consistent plasma levels and improving adherence with biweekly or monthly dosing.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Risperidone Long-Acting Injectable (LAI) suspension is approved by the FDA in the United States and the EMA in the European Union for the treatment of schizophrenia and maintenance therapy in bipolar I disorder. It offers an extended-release formulation designed for intramuscular injection every two weeks or monthly, ensuring steady therapeutic levels and improving medication adherence. Regulatory bodies emphasize its importance in reducing relapse rates and hospitalizations. Prescribers must adhere to initiation protocols, especially when transitioning from oral risperidone. To explore additional forms and strengths of risperidone LAI, visit Pharmatradz.com.

Risperidone Long-Acting Injectable (Lai) Suspension — third party manufacturing & bulk supply

Risperidone Long-Acting Injectable (Lai) Suspension is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Risperidone Long-Acting Injectable (Lai) Suspension is supplied as Long-acting injectable (LAI) suspension — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Risperidone Long-Acting Injectable (Lai) Suspension listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Risperidone Long-Acting Injectable (Lai)... →

Back to Listing

Frequently Asked Questions

Risperidone injection is used for the treatment of schizophrenia and sometimes bipolar disorder. Long-acting formulations are given to patients who need consistent antipsychotic treatment and may have difficulty taking daily oral medication. It helps control symptoms such as hallucinations, delusions, mood changes, and disorganized thinking.

Risperidone injection is made from the active pharmaceutical ingredient risperidone, an atypical antipsychotic compound that works by affecting dopamine and serotonin receptors in the brain. Long-acting injectable versions use specialized delivery systems that release the medicine slowly over time.

The main trade names include Risperdal Consta, Perseris, Uzedy, and Rykindo, along with several regional brand names depending on the country and manufacturer.

Risperdal Consta is manufactured by Janssen Pharmaceuticals (a Johnson & Johnson company). Perseris is produced by Indivior. Uzedy is developed by Teva Pharmaceuticals in collaboration with Medincell. Rykindo is produced by Luye Pharma Group. In India and other markets, various pharmaceutical manufacturers produce risperidone long-acting injections under licensed or local brands.

The generic name is risperidone.

Major brand names include Risperdal Consta, Perseris, Uzedy, and Rykindo.

Risperidone injections are manufactured in multiple countries depending on the brand, including the United States, European Union countries, China, and India, under approved pharmaceutical manufacturing facilities that comply with regulatory standards such as US FDA, EMA, and other national authorities.